| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.002 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | 0.097 | 0.003 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | 0.099 | 0.003 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.093 | 0.003 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | 0.22 | 0.003 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.003 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.087 | 0.004 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.094 | 0.004 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.004 |